Source recordFED

Symvivo Corporation

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2022· $3,071,774· BN 818996241· BC

Description

This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of additional bacTRL-based products including emergent or predicted SARS-CoV-2 variants, as we…

Amendment chain · 4 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $4,571,774 at start, $3,071,774 after amendment #3 (−$1,500,000).

$4,571,774$0Original · 2021-06-01 (start date) · total $4,571,774Amendment 1 · 2022-03-03 · total $4,571,774Amendment 2 · 2022-07-11 · total $4,571,774Amendment 3 · 2023-01-28 · total $3,071,774
  • #02021-06-01$4,571,774
  • #12022-03-03$4,571,774
  • #22022-07-11$4,571,774
  • #32023-01-28$3,071,774-$1,500,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2021-06-01(start date)$4,571,774—This project will involve further development and characterization of oral bacTRL-based vaccines. This work i…
#1 amendment2022-03-03$4,571,774+$0This project will involve further development and characterization of oral bacTRL-based vaccines. This work i…
#2 amendment2022-07-11$4,571,774+$0This project will involve further development and characterization of oral bacTRL-based vaccines. This work i…
#3 amendment2023-01-28$3,071,774−$1,500,000This project will involve further development and characterization of oral bacTRL-based vaccines. This work i…

Related records · 9

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 818996241)

RefDepartment · programCurrent valueFY
GC-WD-DEO-2021-2022-Q4-496Pacific Economic Development Canada | Développement économique Canada pour le Pacifique · Regional Economic Growth through Innovation$650,000FY2022
GC-WD-DEO-2023-2024-Q1-23Pacific Economic Development Canada | Développement économique Canada pour le Pacifique · Regional Economic Growth through Innovation$351,693FY2022
GC-WD-DEO-2024-2025-Q1-25Pacific Economic Development Canada | Développement économique Canada pour le Pacifique · Regional Economic Growth through Innovation$76,693FY2022
172-2020-2021-Q2-956763National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$2,821,081FY2021

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2021-2022-Q1-974484 · retrieved 2026-11-16.